Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -26,868 | -16,591 | N/A | N/A |
| Depreciation Amortization | 23 | 48 | N/A | N/A |
| Accounts receivable | -36 | 49 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,354 | -554 | N/A | N/A |
| Other Working Capital | 3,862 | -2,655 | N/A | N/A |
| Other Operating Activity | -2,926 | 801 | 0 | 0 |
| Operating Cash Flow | $-22,591 | $-18,903 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -33 | -39 | N/A | N/A |
| Purchase Of Investment | 0 | -12,000 | N/A | N/A |
| Sale Of Investment | 1,500 | 17,700 | N/A | N/A |
| Investing Cash Flow | $1,467 | $5,661 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 100 | 15,163 | N/A | N/A |
| Common Stock Issued | 44,285 | 31 | N/A | N/A |
| Other Financing Activity | -3,755 | 0 | 0 | 0 |
| Financing Cash Flow | $40,630 | $15,194 | $N/A | $N/A |
| Beginning Cash Position | 15,646 | 13,693 | N/A | N/A |
| End Cash Position | 35,151 | 15,646 | N/A | N/A |
| Net Cash Flow | $19,505 | $1,952 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -22,591 | -18,903 | N/A | N/A |
| Capital Expenditure | -33 | -39 | N/A | N/A |
| Free Cash Flow | -22,625 | -18,942 | 0 | 0 |